Related Experiment Video

Updated: Aug 7, 2026

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model
05:08

Targeted and Selective Treatment of Pluripotent Stem Cell-derived Teratomas Using External Beam Radiation in a Small-animal Model

Published on: February 17, 2019

Concise review: scientific and ethical roadblocks to human embryonic stem cell therapy

Lori Gruen1, Laura Grabel

  • 1Department of Philosophy, Wesleyan University, Middletown, Connecticut 06459-0170, USA.

Stem Cells (Dayton, Ohio)
|June 24, 2006
PubMed

Insights

Embryonic stem cell therapy shows promise for treating diseases but faces scientific and ethical challenges. Addressing issues like safety, funding, and derivation methods is key to advancing this regenerative medicine approach.

Area of Science:

  • Regenerative Medicine
  • Stem Cell Biology
  • Bioethics

Background:

  • Embryonic stem cells (ESCs) possess significant therapeutic potential for various human diseases and injuries.
  • Progress in clinical applications of ESCs is hindered by several scientific and ethical obstacles.

Purpose of the Study:

  • To identify key scientific and ethical roadblocks impeding the clinical translation of ESC therapies.
  • To explore potential solutions and future directions for overcoming these challenges.

Main Methods:

  • Literature review and expert discussion to identify critical areas of concern.
  • Analysis of six major challenges: tumorigenicity, animal product contamination, genetic compatibility, funding, cell type selection, and derivation methods.

Main Results:

  • Tumorigenicity and contamination pose significant safety risks for ESC-based therapies.
  • Genetic compatibility, funding, and appropriate cell type selection are crucial for successful transplantation.
  • Development of "embryo-friendly" derivation methods is essential for ethical considerations.

Conclusions:

  • Overcoming scientific and ethical hurdles is paramount for realizing the therapeutic potential of ESCs.
  • Strategic advancements in safety, ethics, and methodology are required for clinical progression.
  • Future research should focus on innovative solutions to ensure the safe and effective use of ESCs in regenerative medicine.

More Related Videos

Isolation and Characterization of Mesenchymal Stromal Cells from Human Umbilical Cord and Fetal Placenta07:06

Isolation and Characterization of Mesenchymal Stromal Cells from Human Umbilical Cord and Fetal Placenta

Published on: April 3, 2017

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System08:00

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System

Published on: May 14, 2015

Related Concept Videos

Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...